Related Experiment Video
Updated: Oct 9, 2026

Novel Whole-tissue Quantitative Assay of Nitric Oxide Levels in Drosophila Neuroinflammatory Response
Published on: December 4, 2013
Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and
V E Laubach1, C X Zhang, S W Russell
1University of Virginia, Department of Surgery, Charlottesville 22908, USA. vlaubach@virginia.edu
Abstract:
Upon cytokine induction, inducible nitric oxide synthase (iNOS) mRNA and enzyme activity in DLD-1 cells reached maximal levels at 6 and 8 h, respectively. A 3.7 kb 5'-flanking region of the human iNOS gene was used to prepare luciferase reporter constructs. Upon transfection of these constructs into DLD-1 cells and primary monkey hepatocytes, significant promoter activity was detected in the absence of cytokines, and this activity decreased with successive truncations of the human iNOS promoter. No increase in luciferase activity was observed after cytokine treatment, in spite of the fact that nuclear run-on analysis indicated that iNOS induction in DLD-1 cells was due, in part, to an increase in transcription rate. These results suggest that 3.7 kb of 5'-flanking DNA do not contain all of the elements required for transcriptional induction of the human iNOS gene. This differs from the mouse iNOS gene for which 1.7 kb of 5'-flanking DNA contain most or all of the elements that control iNOS expression in mouse macrophages. Thus, important cell- and species-specific mechanisms may exist for the control of iNOS expression.

